Indian drug companies start off a price war on experimental Covid-19 drug

Over the next few weeks, close to 10 drug companies including Abbott,
Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr
Reddy's Laboratories are expected to launch their own brands of
favipiravir, despite inconclusive evidence of its effectiveness.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-companies-start-off-a-price-war-on-experimental-covid-19-drug/articleshow/77156304.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment